טוען...
Relapse After Allogeneic Hematopoietic Cell Therapy
Relapse of disease remains a major cause of mortality following allogeneic hematopoietic cell therapy (HCT). Over the past decade there has been a tremendous increase in our understanding of the biology underlying the graft-versus-tumor/leukemia (GVT) effect. However, there are several other factors...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3637945/ https://ncbi.nlm.nih.gov/pubmed/19857588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.10.023 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|